LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 929 | 3894 | 3216 | 1.2107 | 1.2253 |
Hs 578T | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 929 | 1264 | 3216 | 0.3929 | 0.1870 |
Hs 578T | Sorafenib | 1.11 | uM | LJP6 | 72 | hr | 929 | 4060 | 3216 | 1.2624 | 1.2779 |
Hs 578T | AZD7762 | 0.12 | uM | LJP6 | 72 | hr | 929 | 1262 | 3216 | 0.3923 | 0.1853 |
Hs 578T | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 929 | 1457 | 3216 | 0.4532 | 0.2857 |
Hs 578T | AZD8055 | 1.11 | uM | LJP6 | 72 | hr | 929 | 1254 | 3216 | 0.3901 | 0.1825 |
Hs 578T | AZD8055 | 10 | uM | LJP6 | 72 | hr | 929 | 1012 | 3216 | 0.3148 | 0.0486 |
Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 929 | 3923 | 3216 | 1.2199 | 1.2347 |
Hs 578T | AT-7519 | 1.11 | uM | LJP6 | 72 | hr | 929 | 868 | 3216 | 0.2699 | -0.0374 |
Hs 578T | AZD7762 | 0.04 | uM | LJP6 | 72 | hr | 929 | 1764 | 3216 | 0.5485 | 0.4302 |
Hs 578T | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 929 | 853 | 3216 | 0.2653 | -0.0466 |
Hs 578T | AZD7762 | 10 | uM | LJP6 | 72 | hr | 929 | 715 | 3216 | 0.2224 | -0.1360 |
Hs 578T | AZD8055 | 0.12 | uM | LJP6 | 72 | hr | 929 | 1326 | 3216 | 0.4123 | 0.2195 |
Hs 578T | AZD8055 | 0.37 | uM | LJP6 | 72 | hr | 929 | 1276 | 3216 | 0.3969 | 0.1938 |
Hs 578T | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 929 | 3200 | 3216 | 0.9948 | 0.9941 |
Hs 578T | AZD7762 | 0.37 | uM | LJP6 | 72 | hr | 929 | 1146 | 3216 | 0.3564 | 0.1243 |
Hs 578T | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 929 | 3783 | 3216 | 1.1761 | 1.1895 |
Hs 578T | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 929 | 3812 | 3216 | 1.1852 | 1.1991 |
Hs 578T | AT-7519 | 0.12 | uM | LJP6 | 72 | hr | 929 | 2782 | 3216 | 0.8649 | 0.8442 |
Hs 578T | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 929 | 967 | 3216 | 0.3006 | 0.0222 |
Hs 578T | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 929 | 737 | 3216 | 0.2291 | -0.1227 |
Hs 578T | AT-7519 | 10 | uM | LJP6 | 72 | hr | 929 | 616 | 3216 | 0.1917 | -0.2056 |
Hs 578T | AZD7762 | 1.11 | uM | LJP6 | 72 | hr | 929 | 1015 | 3216 | 0.3157 | 0.0506 |
Hs 578T | Alvocidib | 0.04 | uM | LJP6 | 72 | hr | 929 | 2245 | 3216 | 0.6982 | 0.6365 |
Hs 578T | Sorafenib | 10 | uM | LJP6 | 72 | hr | 929 | 3036 | 3216 | 0.9439 | 0.9364 |